article · Scientific African
This study presents an ethnobotanical survey of medicinal plants used in the treatment of urogenital disorders in the Drâa-Tafilalet region, located in southeastern Morocco. The survey involved 200 herbalists and medicinal plant vendors across three provinces: Errachidia, Tinghir, and Zagora. Ethnobotanical data were analyzed using metrics such as use value (UV), frequency of citation (FC), relative frequency of citation (RFC), and family importance value (FIV). The study identified 80 species belonging to 44 plant families. The most represented families were Asteraceae (8 species), Lamiaceae (7 species), Apiaceae (7 species), and Fabaceae (6 species). The species most frequently cited treating urogenital disorders included Petroselinum sativum Hoff. (RFC = 0.018), Arenaria rubra L. (RFC = 0.016), Ziziphus lotus (L.) Lank. (RFC = 0.016), Zea mays (RFC = 0.013), Artemisia herba-alba (RFC = 0.013), and Ammi visnaga (RFC = 0.011). Leaves were the most commonly used plant part (35%). The primary preparation methods of these remedies were decoction (53.75%) and infusion (30%), with oral administration being the preferred route (95%). The findings of this study provide a valuable resource for researchers and practioners of traditional medicine, highlighting the importance of Morocco's medicinal flora. This ethnobotanical knowledge not only supports the conservation of national pharmacopoeia but also offers a promising foundation for the discovery of new therapeutic agents, particularly for the treatment of urogenital disorders. Future research could further investigate the bioactive compounds present in the identified species, potentially leading to innovative treatments for urogenital health issues.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.sciaf.2024.e02464
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.